Literature DB >> 862341

Plasma noradrenaline concentrations in experimental renovascular hypertension in the rat.

H J Dargie, S S Franklin, J L Reid.   

Abstract

1. Plasma noradrenaline concentrations and dopamine beta-hydroxylase activity have been measured at various stages in the development of hypertension in the one-kidney Goldblatt rat (unilateral renal arterial constriction and contralateral nephrectomy). 2. Although plasma noradrenaline concentrations were significantly elevated from control values at 7, 14 and 28 days, plasma dopamine beta-hydroxylase activity was not significantly different from control values except at 24 h. 3. These findings suggest that peripheral sympathetic activity is increased in the one-kidney Goldblatt model of experimental hypertension but that plasma dopamine beta-hydroxylase activity is poor index of this increase. 4. Both the rise in blood pressure and the rise in plasma noradrenaline concentrations were prevented by pretreatment with intracisternal 6-hydroxydopamine, suggesting that the increased sympathetic activity is at least in part centrally mediated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862341     DOI: 10.1042/cs0520477

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  5 in total

Review 1.  Renal afferents and hypertension.

Authors:  John Ciriello; Cleusa V R de Oliveira
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Noradrenaline: a circulating inhibitor of sodium transport.

Authors:  A Riozzi; A M Heagerty; R F Bing; H Thurston; J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

4.  Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat.

Authors:  R E Katholi; S R Winternitz; S Oparil
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

Review 5.  Salivary kallikrein excretion in hypertension.

Authors:  A Heidland; A Röckel; G Schmid
Journal:  Klin Wochenschr       Date:  1979-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.